FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to a method for producing a haemostatic composition with anti-lymphorrheic properties and to a haemostatic composition with anti-lymphorrheic properties produced thereby. The production method includes adding a soluble silver salt to a solution of polyacrylic acid (PAA), bringing the pH of the PAA solution to 7-7.4, and heating the PAA solution to 90-125°C. The molecular weight of PAA is from 1,000 to 8,000. The composition includes a matrix of cross-linked silver poly(acrylate) with an affinity for proteins.
EFFECT: claimed composition can be used as a sealing agent for terminating the postoperative leaking of lymph (lymphorrhea) and preventing the formation of seromas posing a significant problem in surgical oncology, abdominal and other areas of surgery.
16 cl, 2 tbl, 15 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COMPLEX COMPOUND OF Co ION AND POLYACRYLIC ACID, HAVING HAEMOSTATIC, ANTIMICROBIAL AND WOUND HEALING PROPERTIES | 2021 |
|
RU2767853C1 |
HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
HEMOSTATIC COMPOSITIONS AND METHODS FOR THEIR PREPARATION | 2017 |
|
RU2756891C2 |
ARGACRYL AS NEW ANTISEPTIC AND HEMOSTATIC AGENT | 2001 |
|
RU2220982C2 |
METHOD FOR WOUND SURFACE HEMOSTASIS AND PREVENTION OF POSTOPERATIVE BLEEDING AFTER TONSILLECTOMY | 2022 |
|
RU2789705C1 |
WOUND COVER WITH HEMOSTATIC ACTION, AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2624242C1 |
EFFICIENT HEMOSTATIC MEDICATION BASED ON LITHIUM AND DOUBLE LITHIUM-ZINC SALT OF POLYACRYLIC ACID | 2008 |
|
RU2424813C2 |
LOCAL HEMOSTATIC AGENT | 2023 |
|
RU2807892C1 |
HEMOSTATIC BIOLOGICALLY ABSORBABLE DEVICE WITH POLYETHYLENE GLYCOL AS A BINDING SUBSTANCE | 2012 |
|
RU2646728C1 |
HEMOSTATIC BIOLOGICALLY ABSORBED DEVICE WITH POLYETHYLENE GLYCOL AS BINDING SUBSTANCE | 2012 |
|
RU2627426C2 |
Authors
Dates
2022-06-21—Published
2021-05-17—Filed